Leading Pharma, LLC recalls Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004…
- Recall date
- September 28, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0085-2018
- FDA classification
- Class II
- Brand / firm
- Leading Pharma, LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Lorazepam Tablets, USP CIV, 0.5 mg, 500-count bottle, Rx Only, Manufactured by: Leading Pharma, LLC Fairfield, NJ 07004 NDC 69315-904-05
Get recall alerts
Free email alert whenever Leading Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Leading Pharma, LLC